Fresenius Medical Care AG & Co KGaA
XETRA:FME
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
DE |
|
Relo Group Inc
F:665
|
JP |
|
Resmed Inc
OTC:RSMDF
|
US |
|
Norsk Hydro ASA
OTC:NHYDY
|
NO |
|
D
|
Delta Air Lines Inc
XMUN:OYC
|
US |
|
Scor SE
PAR:SCR
|
FR |
|
Walmart Inc
MIL:1WMT
|
US |
|
Decidr AI Industries Ltd
ASX:DAI
|
AU |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is FME's stock price target?
Price Target
42.84
EUR
According to Wall Street analysts, the average 1-year price target for FME is 42.84 EUR with a low forecast of 21.94 EUR and a high forecast of 67.2 EUR.
What is the Revenue forecast for Fresenius Medical Care AG & Co KGaA?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 8 years is 4%.
What is the Gross Profit forecast for Fresenius Medical Care AG & Co KGaA?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 8 years is 5%.
What is the Operating Income forecast for Fresenius Medical Care AG & Co KGaA?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Operating Income has been 0%. The projected CAGR for the next 8 years is 8%.
What is the Pre-Tax Income forecast for Fresenius Medical Care AG & Co KGaA?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 0%. The projected CAGR for the next 3 years is 9%.
What is the Net Income forecast for Fresenius Medical Care AG & Co KGaA?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Net Income has been 0%. The projected CAGR for the next 8 years is 8%.